FDA authorizes new monoclonal antibody treatment to fight omicron

(WASHINGTON) -- The Food and Drug Administration has authorized a new monoclonal antibody treatment for COVID-19, shown to hold up against the omicron variant and BA.2 subvariant.The drug, called bebtelovimab from Eli Lilly, is a monoclonal therapy meant for COVID-19 patients as young as...

What to know about antibody tests in a post-vaccine world

(NEW YORK) -- A Centers for Disease Control and Prevention panel once again warned consumers this week not to use commercial antibody tests to check whether or not they are immune to COVID-19. These tests, the panel said Thursday, are not consistent and can't be...